ARTICLE | Clinical News
Lovenox: Began a two-part Phase III trial. The first part of the Thrombin Inhibition in Myocardial Infarction 11 (TIMI 11) trial will enroll 300 patients to det
November 20, 1995 8:00 AM UTC
The second part of the trial, to include more than 3,000 patients, will compare Lovenox against unfractionated heparin. ...